SHC vs UTMD
SHC: A global sterilization and lab testing partner ensuring the safety of medical devices and pharmaceuticals for 40+ top-50 device makers and 9 of top-10 pharma companies. UTMD: Utah Medical Products designs and manufactures specialized medical devices focused on patient safety in critical care, neonatal intensive care, and women's health.
Side-by-side fundamentals
| Metric | SHC | UTMD | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $17.29 | $69.19 | |
| Market cap as of 2026-07-23 | $4.9B | $220M | |
| P/E as of 2026-07-23 | 41.86 | 20.29 | UTMD lower |
| PEG as of 2026-07-23 | 3.82 | n/a | |
| Net margin as of 2026-07-23 | +9.9% | +28.9% | UTMD higher |
| Gross margin as of 2026-07-23 | +55.3% | +57.9% | UTMD higher |
| Operating margin as of 2026-07-23 | +29.0% | +28.8% | SHC higher |
| ROE as of 2026-07-23 | +20.6% | +9.1% | SHC higher |
| ROA as of 2026-07-23 | +3.6% | +8.9% | UTMD higher |
| Debt / equity as of 2026-07-23 | 3.59 | 0.00 | UTMD lower |
| Revenue growth (YoY) as of 2026-07-23 | +7.4% | -4.4% | SHC higher |
| Revenue CAGR (3y) SEC XBRL | +5.1% | -9.7% | SHC higher |
| Dividend yield as of 2026-07-23 | n/a | +1.8% | |
| Beta as of 2026-07-23 | 1.78 | 0.36 | |
| 1-year return as of 2026-07-22 close | +52.2% | +22.6% | SHC higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.